MedTrace Logo

Analysis of Circulating Tumor Markers in the Blood (ALCINA)

NCT02866149 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 682

Last updated 2024-10-01

No results posted yet for this study

Summary

Exploratory study on blood-borne biological markers and their correlation with clinical and pathological characteristics.

Conditions

Interventions

BIOLOGICAL

Blood sampling

Up to 5 blood samplings can be performed at different time points

PROCEDURE

Tumor sampling

One tumor sampling can be performed, if applicable

OTHER

Stool sampling

Up to 5 blood samplings can be performed at different time points

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • François-Clément BIDARD, MD PhD · Institut Curie, Paris (FR)

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2024-07-31
Completion
2024-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02866149 on ClinicalTrials.gov